BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/17/2017 8:10:05 PM | Browse: 209 | Download: 131
Publication Name World Journal of Gastroenterology
Manuscript ID 35758
Country Italy
Category Pharmacology & Pharmacy
Manuscript Type Basic Study
Article Title Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis
Manuscript Source Unsolicited Manuscript
All Author List Daniela Gabbia, Arianna Dalla Pozza, Laura Albertoni, Roberta Lazzari, Giorgia Zigiotto, Maria Carrara, Vincenzo Baldo, Tatjana Baldovin, Annarosa Floreani and Sara De Martin
Funding Agency and Grant Number
Funding Agency Grant Number
Grant from the University of Padova CPDA138721/13
Corresponding Author Sara De Martin, PharmD, PhD, Assistant Professor, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, L.go Meneghetti, 2, Padova 35131, Italy. sara.demartin@unipd.it
Key Words Cholestasis; CYP3A; Drug metabolism; Pregnane X receptor; Constitutive androstane receptor
Core Tip We demonstrated that early- and late-stage cholestasis affects CYP3A-mediated metabolism differently, probably as consequence of the different activation of Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR). As a consequence, cholestatic patients may have an altered drug metabolism: in the early stage due to the induction of CYP3A enzymes; and in the late stage due to the high deposition of fibrotic liver and consequent hepatocyte loss. Secondly, since PXR activation is known to induce alternative hepatic export routes and detoxification enzymes, the induction of these cellular pathways with PXR and/or CAR agonists could be exploited as a therapeutic strategy for the management of cholestatic diseases.
Citation Gabbia D, Dalla Pozza A, Albertoni L, Lazzari R, Zigiotto G, Carrara M, Baldo V, Baldovin T, Floreani A, De Martin S. pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis. World J Gastroenterol 2017; 23(42): 7519-7530
Received
2017-08-05 05:07
Peer-Review Started
2017-08-07 10:04
To Make the First Decision
2017-08-30 02:42
Return for Revision
2017-08-31 07:49
Revised
2017-09-18 09:18
Second Decision
2017-10-11 06:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-10-17 20:10
Articles in Press
2017-10-17 20:10
Publication Fee Transferred
2017-10-30 15:06
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-11-06 04:36
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com